Among the candidate targets, protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), leukocyte common antigen (LAR) interacting protein (liprin), alpha 1 (PPFIA1) may be an important oncogene in CML. This evidence concerns the gene PSMA6 and chronic myelogenous leukemia, BCR-ABL1 positive.